SCHEMBL9899477

SCHEMBL9899477

COc1ccc2c(O)cc3c(c2c1)-c1ccc(-c2ccccc2)cc1C3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
BACE1 P56817 2/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
PTPN1 P18031 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1813707 0.78 MEN1 (0.42) SMN1; SMN2MAPTKDM4EMEN1KMT2A
SCHEMBL25837994 0.78 METAP1 (0.38) SMN1; SMN2MAPTMAPK1MEN1KMT2A
SCHEMBL1812020 0.76 PTPN1 (0.45) SMN1; SMN2MAPTKDM4EMEN1KMT2A
SCHEMBL25837953 0.75 METAP1 (0.40) SMN1; SMN2MAPTMEN1KMT2ANPC1
SCHEMBL1815593 0.75 MEN1 (0.40) SMN1; SMN2MAPTKDM4EMEN1KMT2A
SCHEMBL8511294 0.73 MEN1 (0.38) SMN1; SMN2MAPTMEN1KMT2ABACE1
SCHEMBL28948621 0.73 ALOX5 (0.48) ESR1MAPTKDM4EMEN1KMT2A
SCHEMBL29721357 0.73 ALOX5 (0.48) ESR1MAPTKDM4EMEN1KMT2A
SCHEMBL9898696 0.73 EDNRB (0.40) SMN1; SMN2MAPTKDM4EMEN1KMT2A
SCHEMBL9899175 0.73 SMN1; SMN2 (0.47) SMN1; SMN2MAPTKDM4EMAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9028728-B2 Photochromic materials that include indeno-fused naphthopyrans TRANSITIONS OPTICAL, INC. (US) 2015-05-12 US disclosed
WO-2013086248-A1 PHOTOCHROMIC MATERIALS THAT INCLUDE INDENO-FUSED NAPHTHOPYRANS PPG INDUSTRIES, INC. (US) 2013-06-13 WO disclosed
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans TRANSITIONS OPTICAL INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120145973-A1 Photochromic Materials That Include Indeno-Fused Naphthopyrans NQO1, INTS6, IPO4 ESR1 939/4885SMN1; SMN2 4652/4885MAPT 2224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.